Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients. [electronic resource]
Producer: 20190927Description: 1031-1041 p. digitalISSN:- 1542-6270
- Administration, Oral
- Aged
- Aged, 80 and over
- Bone Density Conservation Agents -- economics
- Cost-Benefit Analysis
- Denosumab -- economics
- Diphosphonates -- administration & dosage
- Fractures, Bone -- epidemiology
- Health Care Costs
- Humans
- Middle Aged
- Osteoporosis -- drug therapy
- Patient Preference -- statistics & numerical data
- Treatment Outcome
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.